Frequency of the TERTRS2853669 polymorphism in melanoma patients residing in the eastern siberia region
- 作者: Belonogov R.N1, Lavrentev S.N1, Palkina N.V1, Komina A.V1, Motorina A.V1, Mikhailova A.K1, Narkevich A.N1, Ruksha T.G1
-
隶属关系:
- V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
- 期: 卷 17, 编号 5 (2019)
- 页面: 53-56
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113153
- DOI: https://doi.org/10.29296/24999490-2019-05-08
- ID: 113153
如何引用文章
详细
全文:
作者简介
R. Belonogov
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
S. Lavrentev
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
N. Palkina
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
A. Komina
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
A. Motorina
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
A. Mikhailova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
A. Narkevich
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
T. Ruksha
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: tatyana_ruksha@mail.ru
参考
- Soura E., Eliades P.J., Shannon K., Stratigos A.J., Tsao H. Hereditary melanoma: update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling. J. Am. Acad. Dermatol. 2016; 74: 411-20.
- Populo H., Boaventura P., Vinagre J., Batista R., Mendes A., Caldas R., Pardal J., Azevedo F., Honavar M., Guimaraes I., Manuel Lopes J., Sobrinho-Simoes M., Soares P. TERT promoter mutations in skin cancer: the effects of sun exposure and X-Irradiation. J. Invest. Dermatol. 2014; 134: 2251-7.
- Kohli J.S., Mir H., Wasif A., Chong H., Akhras V., Kumar R., Nagore E., Bennett D.C. ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression. Oncotarget. 2017; 8: 104408-17.
- Heidenreich B., Nagore E., Rachakonda P.S., Garcia-Casado Z., Requena C., Traves V., Becker J., Soufir N., Hemminki K., Kumar R. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun. 2014; 5: 3401-8.
- Ko E., Seo H.W., Jung E.S., Kim B.H., Jung G. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer. Oncotarget. 2015; 7: 684-99.
- Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A., Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science. 2013; 339: 959-61.
- Nagore E., Heidenreich B., Rachakonda S., Garcia-Casado Z., Requena C., Soriano V., Frank C., Traves V., Quecedo E., Sanjuan-Gimenez J., Hemminki K., Landi M.T, Kumar R. TERT promoter mutations in melanoma survival. Int. J. Cancer. 2016; 139: 75-84.
- Nencha U., Rahimian A., Giry M., Sechi A., Mokhtari K., Polivka M., Schmitt Y., Di Stefano A.L., Alentorn A., Labussiere M., Sanson M. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. J. Neurooncol. 2016; 126 (3): 441-6.
- Shadrina A.S., Boyarskikh U.A., Oskina N.A., Sinkina T.V., Lazarev A.F., Petrova V.D., Filipenko M.L. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population. Tumour Biol. 2015; 36: 841-7.
- Pellegrini C., Maturo M.G., Martorelli C., Suppa M., Antonini A., Kostaki D., Verna L., Landi M.T., Peris K., Fargnoli M.C. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Melanoma Res. 2017; 27: 258-67.